|
 |
|
MedTRACK is the leading on-line Research Tool for Biomedical Intelligence and monitors
every significant development by examining both Financial and Pipeline data.
Among the analyses featured are the Top companies and other statistics based on different categories.
Key Lists
 Top 10 Public Pharmaceutical Companies by Market Value ($ In millions)
| Company Name |
Symbol |
Share Price |
Mkt.Value |
SPC1M (%) |
| Johnson & Johnson |
JNJ |
65.59 |
179,208.34 |
-0.44 |
| Pfizer Inc |
PFE |
21.11 |
162,271.87 |
-3.91 |
| F. Hoffmann-La Roche Ltd |
ROG |
153.00 |
141,807.18 |
-5.50 |
| Novartis AG |
NVS |
55.66 |
134,624.84 |
-4.33 |
| Merck & Co Inc |
MRK |
38.44 |
117,316.87 |
0.37 |
| GlaxoSmithKline plc |
GSK |
13.96 |
109,804.24 |
-5.96 |
| Sanofi (formerly Sanofi-aventis) |
SAN |
55.79 |
98,584.81 |
-2.62 |
| Abbott Laboratories |
ABT |
54.45 |
84,821.97 |
-4.00 |
| Novo Nordisk A/S |
NOVO B |
709.50 |
70,786.36 |
6.05 |
| AstraZeneca Plc |
AZN |
47.21 |
62,789.30 |
-1.07 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 10 Public Biotech Companies by Market Value ($ In millions)
| Company Name |
Symbol |
Share Price |
Mkt.Value |
SPC1M (%) |
| Amgen Inc |
AMGN |
69.62 |
61,195.98 |
8.59 |
| Biogen Idec Inc |
BIIB |
121.26 |
29,456.16 |
6.84 |
| Kamada Ltd. |
KMDA |
3,034.00 |
20,444.23 |
-- |
| CSL Limited |
CSL |
30.44 |
17,118.46 |
-4.99 |
| Life Technologies Corporation |
LIFE |
48.86 |
8,731.59 |
19.93 |
| Elan Corporation plc |
ELN |
13.65 |
8,028.93 |
1.41 |
| Kyowa Hakko Kirin Co Ltd |
Stock Code Number : 4151 |
917.00 |
6,813.61 |
-2.96 |
| Celltrion Inc |
Stock Code Number : A068270 |
37,650.00 |
3,891.05 |
5.31 |
| United Therapeutics Corporation |
UTHR |
50.00 |
2,916.72 |
4.56 |
| Cubist Pharmaceuticals Inc |
CBST |
41.68 |
2,562.41 |
6.73 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 20 Public Pharmaceutical Companies By Sales ($ in millions) for 2010
| Company Name |
Symbol |
Share Price |
SalesValue |
SPC1M (%) |
| Pfizer Inc |
PFE |
21.11 |
67,809.00 |
-3.91 |
| Johnson & Johnson |
JNJ |
65.59 |
61,587.00 |
-0.44 |
| F. Hoffmann-La Roche Ltd |
ROG |
153.00 |
55,637.38 |
-5.50 |
| Novartis AG |
NVS |
55.66 |
50,624.00 |
-4.33 |
| Bayer Ag |
BAYN |
54.71 |
48,863.55 |
6.94 |
| Merck & Co Inc |
MRK |
38.44 |
45,987.00 |
0.37 |
| GlaxoSmithKline plc |
GSK |
13.96 |
45,546.45 |
-5.96 |
| Sanofi (formerly Sanofi-aventis) |
SAN |
55.79 |
42,312.76 |
-2.62 |
| Abbott Laboratories |
ABT |
54.45 |
35,166.72 |
-4.00 |
| AstraZeneca Plc |
AZN |
47.21 |
33,269.00 |
-1.07 |
| Eli Lilly & Co |
LLY |
39.60 |
23,076.00 |
-5.26 |
| Bristol-Myers Squibb Company |
BMY |
32.31 |
19,484.00 |
-6.81 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
3,320.00 |
16,606.80 |
-2.64 |
| Teva Pharmaceutical Industries Ltd |
TEVA |
45.91 |
16,121.00 |
6.52 |
| Merck KGaA |
MRK |
81.35 |
12,938.09 |
3.06 |
| Novo Nordisk A/S |
NOVO B |
709.50 |
11,359.03 |
6.05 |
| Daiichi Sankyo Company Limited |
Stock Code Number : 4568 |
1,386.00 |
11,318.17 |
-9.06 |
| Astellas Pharma Inc. |
Stock Code Number : 4503 |
3,205.00 |
11,161.18 |
2.07 |
| Eisai Co Ltd |
Stock Code Number : 4523 |
3,180.00 |
8,996.29 |
-0.16 |
| Gilead Sciences Inc |
GILD |
49.31 |
7,949.42 |
17.80 |
| *SPC1M - Share Price Change in 1 month (%) | ^Top |
Top 20 Public Pharmaceutical Companies by R&D Spending ($ in millions) for 2010
| Company Name |
Symbol |
R&D |
| F. Hoffmann-La Roche Ltd |
ROG |
10,267.01 |
| Pfizer Inc |
PFE |
9,379.00 |
| Novartis AG |
NVS |
8,196.00 |
| Merck & Co Inc |
MRK |
8,122.00 |
| Johnson & Johnson |
JNJ |
6,844.00 |
| GlaxoSmithKline plc |
GSK |
6,136.07 |
| Sanofi (formerly Sanofi-aventis) |
SAN |
6,128.83 |
| Eli Lilly & Co |
LLY |
4,884.20 |
| Bayer Ag |
BAYN |
4,251.61 |
| AstraZeneca Plc |
AZN |
4,093.00 |
| Abbott Laboratories |
ABT |
3,572.42 |
| Bristol-Myers Squibb Company |
BMY |
3,424.00 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
3,379.83 |
| Astellas Pharma Inc. |
Stock Code Number : 4503 |
2,542.70 |
| Daiichi Sankyo Company Limited |
Stock Code Number : 4568 |
2,273.66 |
| Merck KGaA |
MRK |
1,945.60 |
| Novo Nordisk A/S |
NOVO B |
1,794.61 |
| Eisai Co Ltd |
Stock Code Number : 4523 |
1,696.85 |
| Celgene Corporation |
CELG |
1,128.49 |
| UCB SA |
UCB |
981.78 |
^Top
Top 20 Public Companies by Number of Employees
| Company Name |
Symbol |
No. of Employees |
| Novartis AG |
NVS |
121,000 |
| Johnson & Johnson |
JNJ |
114,000 |
| Bayer Ag |
BAYN |
113,200 |
| Pfizer Inc |
PFE |
106,500 |
| Sanofi (formerly Sanofi-aventis) |
SAN |
101,575 |
| GlaxoSmithKline plc |
GSK |
100,000 |
| Merck & Co Inc |
MRK |
94,000 |
| Abbott Laboratories |
ABT |
90,000 |
| F. Hoffmann-La Roche Ltd |
ROG |
76,767 |
| AstraZeneca Plc |
AZN |
61,100 |
| Merck KGaA |
MRK |
40,849 |
| Teva Pharmaceutical Industries Ltd |
TEVA |
39,660 |
| Eli Lilly & Co |
LLY |
38,350 |
| Novo Nordisk A/S |
NOVO B |
32,016 |
| Daiichi Sankyo Company Limited |
Stock Code Number : 4568 |
30,488 |
| Bristol-Myers Squibb Company |
BMY |
27,000 |
| Takeda Pharmaceutical Company Limited |
Stock Code Number : 4502 |
18,498 |
| Mylan Inc |
MYL |
18,000 |
| Astellas Pharma Inc. |
Stock Code Number : 4503 |
16,279 |
| Dr Reddys Laboratories Ltd |
Stock Code Number : 500124 |
14,900 |
^Top
Top Mergers and Acquisitions for 2011
| Acquirer |
Target |
M&A Date |
M&A Price in $millions |
| Express Scripts, Inc. (ESRX) |
Medco Health Solutions, Inc. (formerly Merck Medco Managed Care LLC) (MHS) |
July 20, 2011 |
29,100.00 |
| Johnson & Johnson (JNJ) |
Synthes, Inc. (SYST) |
April 27, 2011 |
21,300.00 |
| Takeda Pharmaceutical Company Limited (4502) |
Nycomed International Management GmbH |
September 30, 2011 |
13,682.40 |
| E. I. du Pont de Nemours and Company (DD) |
Danisco A/S (DCO) |
January 09, 2011 |
7,137.46 |
| HCP, Inc. (formerly Health Care Property Investors, Inc.) (HCP) |
HCR ManorCare, Inc. - Real Estate Assets - US |
April 08, 2011 |
6,100.00 |
| Thermo Fisher Scientific, Inc. (Formerly Thermo Electron Corporation) (TMO) |
Phadia AB |
August 23, 2011 |
3,520.37 |
| Endo Pharmaceuticals Holdings, Inc. (ENDP) |
American Medical Systems Holdings, Inc. (AMMD) |
June 20, 2011 |
2,900.00 |
| Terumo Corporation (4543) |
CaridianBCT, Inc. |
April 14, 2011 |
2,628.00 |
| Cargill, Incorporated |
Provimi SA (VIM) |
November 22, 2011 |
2,138.13 |
| Fresenius Medical Care AG & Co. KGaA (FME) |
Liberty Dialysis Holdings, Inc. |
August 01, 2011 |
1,700.00 |
^Top
Drugs under development
The following section shows the number of drugs either in development or awaiting regulatory approval.
| Therapeutic Category | No. of Unique Products* | | Autoimmune & Inflammatory Diseases (Allergy, Graft Versus Host Disease, Lupus, Rheumatoid Arthritis...) | 977 | | Blood and Lymphatic Diseases (Anemia, Hemophilia, Thrombocythaemia...) | 346 | | Cardiovascular & Circulatory Disorders (Congestive Heart Failure, Angina Pectoris, Atherosclerosis...) | 614 | | Cancer (Leukemia, Colorectal Cancer, Small Cell Lung Cancer, Melanoma...) | 4,482 | | Central Nervous System (Alzheimer's Disease, Parkinson's Disease, Depression, epilepsy...) | 1,792 | | Dental (Caries, Dental Implant Systems, Dental Pain...) | 39 | | Dermatology (Psoriasis, Acne, Diabetic Ulcers...) | 481 | | Digestive System ( Duodenal Ulcer, Gastroesophageal Reflux Disease, Ulcerative Colitis...) | 452 | | Genetic Diseases (Gaucher's Disease, Mucopolysaccharidosis-I, Turner's Syndrome...) | 100 | | Infections (AIDS/HIV, Bacterial Infections,Hepatitis...) | 1,648 | | Kidneys & Genito-Urinary System (Urinary Incontinence, Nephritis,Erectile Dysfunction...) | 315 | | Metabolic/Endocrinology Disorders (Diabetes, Growth Hormone Deficiency, Acromegaly...) | 926 | | Musculoskeletal Disorders (Bone Diseases, Muscle Pain, Osteopetrosis...) | 303 | | Ophthalmology (Cataract, Choroidal Neovascularization (CNV), CMV Retinitis...) | 376 | | Respiratory Disorders (Asthma, Chronic Obstructive Pulmonary Disease, Respiratory Syncytial Virus (RSV) Infection...) | 604 | | Substance Abuse (Alcoholism, Drug Abuse, Methanol Poisoning, Smoking Cessation...) | 77 | | Women's Health (Ovarian Cancer, Breast Cancer, Endometriosis, Menopausal Symptoms...) | 204 | | *Above counts represent unique products in trial phases PC, I, II, III and PA. | ^Top |
|
|
|
|
|
|
 |
|
MedTRACK's Mission
To serve the pharmaceutical, biotechnology and financial industries and their supporting
vendors with high-quality, comprehensive corporate intelligence on biomedical companies
around the world.
|
|
 | |
 |
|
|
